Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
This clinical trial update reports that the Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) study is actively recruiting by invitation…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib
A completed medical-records study in Spain assessed diarrhea management in patients with idiopathic pulmonary fibrosis treated with nintedan…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis [NA]
A completed clinical trial assessing the effectiveness of pulmonary rehabilitation on oxygen saturation in patients with idiopathic pulmonar…
-
CLINICAL_TRIALS withdrawal · 2025-06-22Clinical Trial Update: Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 safety and tolerability study of macitentan in patients with idiopathic pulmonary fibrosis was withdrawn. No results or ongoing enro…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Daoyin Technique for Improving Exercise Endurance in IPF [NA]
A clinical trial evaluating Daoyin technique to improve exercise endurance in Idiopathic Pulmonary Fibrosis is listed as not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
This clinical trial update notes a Phase 2 long-term safety and efficacy study of HSK44459 tablets in idiopathic pulmonary fibrosis, with re…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients
A clinical trial evaluating a Londrina Activities of Daily Living protocol in patients with idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS other · 2025-05-30Clinical Trial Update: Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 1]
The Phase 1 clinical trial evaluating Orin1001 for idiopathic pulmonary fibrosis has been suspended, according to sponsor Orinove, Inc.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough [Phase 2]
Phase 2 study evaluating nalbuphine extended-release for cough in idiopathic pulmonary fibrosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF [Phase 2]
Phase 2 trial evaluating safety, efficacy, and pharmacokinetics of C21 in idiopathic pulmonary fibrosis has completed and results have been …
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Downhill Walking in IPF [NA]
A clinical trial evaluating downhill walking as an intervention for idiopathic pulmonary fibrosis is currently recruiting at Saglik Bilimler…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Study of the Natural Progression of Interstitial Lung Disease (ILD)
An ongoing University of Chicago study aims to characterize the natural progression of interstitial lung diseases. The study includes idiopa…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: A Trial of HRS-9813 in Healthy Subjects [Phase 1]
Phase 1 clinical trial evaluating HRS-9813 in healthy subjects, sponsored by Guangdong Hengrui Pharmaceutical, with listed conditions includ…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Turkish Validity and Reliability of SGRQ-I
Turkish clinical study to validate and assess the reliability of the Turkish version of the St. George's Respiratory Questionnaire for Idiop…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD
This update notes that the trial investigating coping strategies within pulmonary rehabilitation for idiopathic pulmonary fibrosis and chron…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: BPF Genetics of ILD Study
This update notes that the BPF Genetics of Interstitial Lung Disease study (NCT03747627) sponsored by University of Dundee is currently acti…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation
A clinical study evaluating end-expiratory trans-pulmonary pressure guided PEEP titration in mechanically ventilated patients with idiopathi…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study
Clinical trial update investigating inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis [Phase 1]
Phase 1 clinical trial update for CMR316 evaluating safety and pharmacology in healthy volunteers and patients with idiopathic pulmonary fib…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
A Zhejiang University-sponsored retrospective study examines perioperative risk factors that influence prognosis after lung transplantation.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF [Phase 1]
Phase 1 clinical trial update assessing the safety of intravenously infused cultured allogeneic umbilical cord-derived mesenchymal stem cell…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: The Effect Of Baduanjin Exercises In Patients With Idiopathic Pulmonary Fibrosis [NA]
This clinical trial update reports the completion of a study evaluating the effect of Baduanjin exercises in patients with idiopathic pulmon…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Pulmonary Fibrosis Foundation Community Registry
The Pulmonary Fibrosis Foundation Community Registry trial (NCT05382572) is currently recruiting. It aims to collect data on patients with p…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ME-015 (suplatast tosilate) for cough associated with idiopathic pulmonary fibr…
-
CLINICAL_TRIALS withdrawal · 2025-04-09Clinical Trial Update: A Study to Investigate Leramistat in Patients With IPF [Phase 2]
A Phase 2 clinical trial evaluating Leramistat for idiopathic pulmonary fibrosis has been withdrawn.